Alzheimer's Association International Conference 2015
AAIC 2015 Coverage
Researchers examine age-related alterations in memory.
Treatment on open wards was linked to lower odds of suicide attempts and to absconding with and without return.
Contraindicated pregnancy medications
Researchers identified increased fibrinogen levels and amyloid-β deposits in the blood vessels and brain parenchyma of patients with Alzheimer's disease.
Study links heavy cannabis use in male teens to increased mortality by age 60.
Cognitive behavioral therapy techniques improve time to resolution of depression in teens who refuse antidepressants.
Researchers found an elevated risk of dementia after adjustment for age, sex, and comorbidities.
Those taking atypical antipsychotics also showed a higher risk of developing type 2 diabetes.
A disproportionate number of patients with mental illness are obese compared to the general population.
Higher educational level and increased cognitive activity has been associated with less amyloid deposition in APOE4 carriers.
Visits to the emergency department for out-of-state individuals increased following legalization of cannabis in Colorado.
A few doctors account for a disproportionately large number of paid malpractice claims.
Odds of autism further increased among mothers with both polycystic ovary syndrome and obesity.
Studies in mice, monkeys point to a compound that might lessen levodopa's debilitating effects, such as restless muscle movements.
However, losing weight might be able to slow the rate of onset.
Aerobic exercise, such as walking, running or swimming, can reduce a range of symptoms of neurocognitive disorders.
A five question screening tool focusing on middle-age educational and occupational attainment helps predict dementia risk.
Currently FDA-approved for treating pseudo bulbar affect, the drug also benefits agitation.
The first randomized-controlled clinical trials are underway to assess if early access to amyloid imaging PET scan results can inform treatment decisions for mild cognitive impairment and dementia.
The big question now is what doses will Biogen examine in aducanumab phase 3 trials.
RVT-101 improved cognition and function when combined with donepezil in patients with mild to moderate Alzheimer's disease.
Greater intake of caffeine among healthy older adults was associated with better memory and executive functioning.
Investigators identified a possible disease-modifying effect of solanezumab as an early treatment for Alzheimer's disease, but the benefit in clinical practice remains unclear.
Dementia patients who were younger, female and lived in nursing homes were most associated with psychotropic polypharmacy.
Among those with mild cognitive impairment, women's cognitive abilities deteriorated twice as quickly as men.
Researchers have begun enrolling 800 patients with a neurodegenerative disorder to test the accuracy of the PredictND tool.
Better balance needed between cure, prevention, and care for patients with dementia.
The sensors could potentially lead to new treatments as well as early disease detection.
Watching too much television and not getting enough physical activity both greatly increase cognitive decline in adults by mid-life.
By 2050, half of all baby boomers are expected to be diagnosed with Alzheimer's, dramatically increasing Medicare spending on it.
Monoclonal antibodies targeting tau and amyloid beta in Alzheimer's disease may benefit other neurodegenerative diseases.
Early academic performance may be better indicator of cognitive reserve than formal education, occupational complexity.
Burden of cognitive impairment may be greater in this vulnerable population, who require vigilance and constant self-care.
Researchers identify significantly higher levels of neurogranin in patients with Alzheimer's disease versus cognitively normal patients.
Elderly patients who were diagnosed with major depression and who carried the APOE-e4 allele had greater cognitive decline.
In patients with mild cognitive impairment, a holistic, multidisciplinary intervention improved attention, concentration, and problem solving.
NPT088, from NeuroPhage Pharmaceuticals, targets proteins related to amyloid beta, tau.
TRV 101, from Treventis Corp., may prevent the formation of beta amyloid.
Metabolites detected in saliva test can be added to the diagnostic armamentarium in Alzheimer's disease.
Researchers have identified biomarkers that have the potential to identify those at risk of developing Alzheimer's disease.
Sign Up for Free e-newsletters
Check out what's trending
Psychiatry Advisor Articles
- Monetary Incentives Improve Cessation in Mentally Ill Smokers
- Obsessive Compulsive Disorder Associated With Decreased Educational Attainment
- Fluvoxamine Effective for Depression in Patients With Neurological Disorders
- When and How to Initiate Driving Cessation Conversation for Dementia Patients
- Memory Scores Have Limited Value as Early Alzheimer Disease Screening Tools
- Nutritional Psychiatry: Emerging Evidence and Expert Interview
- FDA Approval: Once-Monthly Buprenorphine Injection for Opioid Use Disorder
- Posttreatment Brain Effects of Psilocybin in Patients With Treatment-Resistant Depression
- Bipolar Disorder, Borderline Personality Disorder May Represent the Same Disorder
- Borderline Personality Disorder: Not Just an Adult Condition
- Depression Screening Tools Accurate in Post-Acute Coronary Syndrome
- Antidepressant Effectiveness for Depression in Schizophrenia
- Higher Rates of Psychotic Incidence in Younger Men, Racial Minorities
- Healthcare Inequality in America: Senator Bernie Sanders's Advisors on Causes and Solutions
- Code of Ethics and New Regulations for Human Research